Sensus Healthcare, Inc. (NASDAQ:SRTS – Get Rating) CEO Joseph C. Sardano sold 36,093 shares of the business's stock in a transaction dated Tuesday, August 9th. The shares were sold at an average price of $13.97, for a total transaction of $504,219.21. Following the completion of the transaction, the chief executive officer now owns 1,294,200 shares in the company, valued at approximately $18,079,974. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Sensus Healthcare Stock Up 0.3 %
Shares of SRTS traded up $0.04 during trading hours on Thursday, reaching $14.09. 257,488 shares of the company traded hands, compared to its average volume of 295,234. The company's fifty day moving average price is $9.51 and its two-hundred day moving average price is $9.23. The company has a market capitalization of $234.99 million, a price-to-earnings ratio of 9.33 and a beta of 0.78. Sensus Healthcare, Inc. has a 12 month low of $3.21 and a 12 month high of $14.82.
Get
Sensus Healthcare alerts:
Analyst Ratings Changes
Separately, Maxim Group restated a "buy" rating and issued a $14.00 price objective on shares of Sensus Healthcare in a research report on Friday, May 6th.
Institutional Investors Weigh In On Sensus Healthcare
A number of large investors have recently modified their holdings of the stock. Bailard Inc. boosted its stake in shares of Sensus Healthcare by 3.9% during the 2nd quarter. Bailard Inc. now owns 34,600 shares of the company's stock valued at $266,000 after purchasing an additional 1,300 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its stake in shares of Sensus Healthcare by 83.3% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,500 shares of the company's stock valued at $40,000 after purchasing an additional 2,500 shares in the last quarter. Northern Trust Corp boosted its stake in shares of Sensus Healthcare by 15.0% during the 1st quarter. Northern Trust Corp now owns 24,602 shares of the company's stock valued at $249,000 after purchasing an additional 3,203 shares in the last quarter. Sheaff Brock Investment Advisors LLC boosted its stake in shares of Sensus Healthcare by 16.3% during the 1st quarter. Sheaff Brock Investment Advisors LLC now owns 25,264 shares of the company's stock valued at $255,000 after purchasing an additional 3,550 shares in the last quarter. Finally, State Street Corp boosted its stake in shares of Sensus Healthcare by 8.9% during the 1st quarter. State Street Corp now owns 46,052 shares of the company's stock valued at $466,000 after purchasing an additional 3,765 shares in the last quarter. Institutional investors own 20.49% of the company's stock.
About Sensus Healthcare
(Get Rating)
Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.
Read More
- Get a free copy of the StockNews.com research report on Sensus Healthcare (SRTS)
- Why Invest in High-Yield Dividend Stocks?
- Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
- Find and Profitably Trade Stocks at 52-Week Lows
- Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
- 3 Stable Growth Stocks for Bumpy Times
Receive News & Ratings for Sensus Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensus Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
